Key statistics
On Friday, Omeros Corp (3O8:DUS) closed at 9.20, -39.15% below its 52-week high of 15.11, set on Jan 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 8.81 |
|---|---|
| High | 9.20 |
| Low | 8.81 |
| Bid | 9.42 |
| Offer | 9.57 |
| Previous close | 9.59 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 70.90m |
| Free float | 68.92m |
| P/E (TTM) | -- |
| Market cap | 761.47m USD |
| EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 15:00 GMT.
More ▼
Press releases
- Omeros Announces First Commercial Sales of YARTEMLEA®
- Omeros Announces New Date for YARTEMLEA® Approval Conference Call
- FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
- Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
- Omeros Corporation Reports Third Quarter 2025 Financial Results
- Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
More ▼
